Table 4. Adverse events.

Patient		1	2	3	4	5	6	7	8
Hematologic events
	Thrombocytopenia (gr)	4	3	1	3	2	3	4a	4
	Leukopenia (gr)	4	4	4	4	1	4	4	4
	Anemia (gr)	3	2	2	2	2	2	3b	3b
	Lymphopenia (gr)	3	3	3	4	3	4	3	3
	Neutropenia (gr)	4	4	4	n/a	-	4	n/a	n/a
Non-hematologic events
	Elevated AST (gr)	2	2	1	3	3	1	2	-
	Elevated ALT (gr)	1	1	-	n/a	n/a	2	-	-
	Elevated bilirubin (gr)	2	-	-	n/a	n/a	2	-	-
	Fever, treatment related (gr)	2	1	-	-	1	1	-	-
	Nausea (gr)	-	1	2	-	1	1	2	-
	Alopecia (gr)	1	-	-	-	-	-	-	1
	Other	c	-	d	-	e	-	-	f

Note: All patients received a subcutaneous injection of granulocyte-colony stimulating factor within 72h after each M-PHP procedure.

AST, aspartate transaminase; ALT, alanine transaminase; Bili, bilirubin; Gr, grade; n/a, not available; -, no adverse event.

^a Treated with platelet transfusion.

^b Treated with red blood cell transfusion.

^c Haemorrhage groin, treated with a tight pressure dressing.

^d Peripheral edema due to periprocedural overhydration, treated with diuretics.

^e Lower urinary tract infection, treated with oral antibiotics.

^f Aneurysma spurium, successfully treated with a thrombin injection.